Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Chuke E. Nwachuku · SciRah

Researcher profile · Semantic Scholar

Chuke E. Nwachuku

Share profile

Chuke E. Nwachuku — researcher profile on SciRah

h-index: 18
Works: 32
Citations: 7,354

Most-cited papers

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
C. Furberg, Jackson T. Wright, B. Davis, J. Cutler +53 more
2002Journal of the American Medical Association (JAMA)5,376 citations
Semantic Scholar
Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Mahboob Rahman, S. Pressel, B. Davis, Chuke E. Nwachuku +14 more
2005Archives of Internal Medicine342 citations
Semantic Scholar
The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT): clinical center recruitment experience.
Jackson T. Wright, W. Cushman, B. Davis, J. Barzilay +11 more
2001Controlled Clinical Trials290 citations
Semantic Scholar
Clinical outcomes in antihypertensive treatment of type 2 diabetes, impaired fasting glucose concentration, and normoglycemia: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
P. Whelton, J. Barzilay, W. Cushman, B. Davis +13 more
2005Archives of Internal Medicine263 citations
Semantic Scholar
Cardiovascular Outcomes in High-Risk Hypertensive Patients Stratified by Baseline Glomerular Filtration Rate
Mahboob Rahman, S. Pressel, B. Davis, Chuke E. Nwachuku +15 more
2006Annals of Internal Medicine218 citations
Semantic Scholar
Clinical Events in High-Risk Hypertensive Patients Randomly Assigned to Calcium Channel Blocker Versus Angiotensin-Converting Enzyme Inhibitor in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
F. Leenen, Chuke E. Nwachuku, H. Black, W. Cushman +15 more
2006HYPERTENSION166 citations Open access
Semantic Scholar
Metabolic and Clinical Outcomes in Nondiabetic Individuals With the Metabolic Syndrome Assigned to Chlorthalidone, Amlodipine, or Lisinopril as Initial Treatment for Hypertension
H. Black, Barry J. Davis, J. Barzilay, Chuke E. Nwachuku +8 more
2007Diabetes Care100 citations
Semantic Scholar
Edoxaban Plus Aspirin vs Dual Antiplatelet Therapy in Endovascular Treatment of Patients With Peripheral Artery Disease: Results of the ePAD Trial
F. Moll, I. Baumgartner, M. Jaff, Chuke E. Nwachuku +9 more
2018Journal of Endovascular Therapy87 citations Open access
Semantic Scholar
The prevalence of reduced glomerular filtration rate in older hypertensive patients and its association with cardiovascular disease: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
Mahboob Rahman, Clinton D. Brown, J. Coresh, B. Davis +7 more
2004Archives of Internal Medicine81 citations
Semantic Scholar
A double-blind, randomized, multicenter phase 2 study of prasugrel versus placebo in adult patients with sickle cell disease
T. Wun, D. Soulières, A. Frelinger, L. Krishnamurti +12 more
2013Journal of Hematology & Oncology72 citations Open access
Semantic Scholar
The Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Heart Failure Validation Study: diagnosis and prognosis.
P. Einhorn, B. Davis, B. Massie, W. Cushman +5 more
2007American Heart Journal63 citations
Semantic Scholar
Incidence and Predictors of Angioedema in Elderly Hypertensive Patients at High Risk for Cardiovascular Disease: A Report From the Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
L. Piller, C. Ford, Barry R. Davis, Chuke E. Nwachuku +4 more
2006The Journal of Clinical Hypertension59 citations Open access
Semantic Scholar
Use of the factorial design and quadratic response surface models to evaluate the fosinopril and hydrochlorothiazide combination therapy in hypertension.
James L. Pool, William C. Cushman, R. Saini, Chuke E. Nwachuku +1 more
1997American Journal of Hypertension49 citations
Semantic Scholar
Cost-effectiveness of Chlorthalidone, Amlodipine, and Lisinopril as First-step Treatment for Patients with Hypertension: An Analysis of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
P. Heidenreich, B. Davis, J. Cutler, C. Furberg +5 more
2008Journal of general internal medicine39 citations Open access
Semantic Scholar
ORIGINAL PAPERS
William C. Cushman, C. Ford, J. Cutler, Karen L. Margolis +14 more
200728 citations Open access
Semantic Scholar
Health-related quality of life and cost-effectiveness components of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: rationale and design.
M. Sullivan, Roger T. Anderson, D. Aron, Hal Atkinson +10 more
2007American Journal of Cardiology27 citations Open access
Semantic Scholar
Operational aspects of terminating the doxazosin arm of The Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
S. Pressel, B. Davis, Jackson T. Wright, T. Geraci +10 more
2001Controlled Clinical Trials20 citations Open access
Semantic Scholar
A Review of Antithrombotic Therapy and the Rationale and Design of the Randomized Edoxaban in Patients With Peripheral Artery Disease (ePAD) Trial Adding Edoxaban or Clopidogrel to Aspirin After Femoropopliteal Endovascular Intervention
M. Tangelder, Chuke E. Nwachuku, M. Jaff, I. Baumgartner +8 more
2015Journal of Endovascular Therapy18 citations Open access
Semantic Scholar
Characteristics and Lipid Distribution of a Large, High‐Risk, Hypertensive Population: The Lipid‐Lowering Component of the Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
V. Papademetriou, L. Piller, C. Ford, D. Gordon +9 more
2003The Journal of Clinical Hypertension13 citations Open access
Semantic Scholar
Blood pressure control in the anthihypertensive and lipid lowering treatment to prevent heart attack trial (ALLHAT)
W. Cushman, H. Black, J. Probstfield, J. Holland +5 more
199812 citations
Semantic Scholar
Re: Hawkins RG, Houston MC Is population-wide diuretic use directly associated with the incidence of end-stage renal disease in the United States? A hypothesis. Am J Hypertens. 2005 Jun;18(6):744-9.
Mahboob Rahman, Chuke E. Nwachuku, P. Whelton, J. Probstfield +1 more
2006American Journal of Hypertension6 citations
Semantic Scholar
The explosion of morbidity and mortality trials in hypertension
Chuke E. Nwachuku, J. Cutler
1997Current opinion in nephrology and hypertension6 citations
Semantic Scholar
Rationale and design of the TAXUS Libertē Post-Approval Study: examination of patients receiving the TAXUS Liberté stent with concomitant prasugrel therapy in routine interventional cardiology practice.
K. Garratt, David P. Lee, E. Rose, Kellie J Windle +5 more
2012American Heart Journal4 citations
Semantic Scholar
A Randomized, Double-Blind, Adaptive Phase 2 Multi-Center Study of Prasugrel Compared to Placebo in Adults with Sickle Cell Disease
T. Wun, D. Soulières, L. Krishnamurti, A. Kutlar +7 more
20114 citations
Semantic Scholar
Angioedema in the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)
L. Piller, C. Ford, B. Davis, Chuke E. Nwachuku +5 more
20052 citations Open access
Semantic Scholar
OR-16: Outcomes in high risk hypertensives randomized to CCB vs ACE inhibitor in ALLHAT
F. Leenen, Chuke E. Nwachuku, W. Cushman, H. Black +2 more
20051 citations Open access
Semantic Scholar
Biomarkers of Hemostatic Activation in a Randomized, Double-Blind, Phase 2 Study of Prasugrel Compared to Placebo in Adults with Sickle Cell Disease
T. Wun, C. Knupp, L. McMahon, John J. Strouse +6 more
20110 citations
Semantic Scholar
¿En enfermos hipertensos de alto riesgo, el tratamiento con amlodipino o lisinopril mejora el pronóstico cardiovascular frente a la clortalidona independientemente del grado de insuficiencia renal? Comentarios
Mahboob Rahman, S. Pressel, Barry R. Davis, Chuke E. Nwachuku +15 more
20070 citations
Semantic Scholar
Comment on: Is population-wide diuretic use directly associated with the incidence of end-stage renal disease in the united states? A hypothesis. by Hawkins RG et al
Mahboob Rahman, Chuke E. Nwachuku, P. Whelton, J. Probstfield +1 more
20060 citations
Semantic Scholar
Trial the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Calcium Channel Blocker Versus Angiotensin-Converting Enzyme Inhibitor in Clinical Events in High-Risk Hypertensive Patients Randomly
J. Haywood, S. Jafri, M. Proschan, U. Thadani +16 more
20060 citations
Semantic Scholar
OR-28: Baseline characteristics of participants in the lipid lowering component of ALLHAT
V. Papademetriou, D. Gordon, T. Hartney, T. Geraci +8 more
20030 citations Open access
Semantic Scholar
D054: Visit (VAd) and Medication Adherence (MAd) in the Antihypertensive and Lipid Lowering treatment to prevent Heart Attack Trial (ALLHAT): Effect of age and other factors
Chuke E. Nwachuku, J. Probstfield, C. Ford, G. Payne +1 more
19980 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

B. Davis×14
Invite
B. Davis — researcher profile on SciRah
P. Whelton×9
Invite
P. Whelton — researcher profile on SciRah
C. Ford×9
Invite
C. Ford — researcher profile on SciRah
S. Pressel×9
Invite
S. Pressel — researcher profile on SciRah

×8

Invite

H. Black — researcher profile on SciRah

Invite

W. Cushman — researcher profile on SciRah

J. Probstfield×8

Invite

J. Probstfield — researcher profile on SciRah

Invite

L. Piller — researcher profile on SciRah

Jackson T. Wright×6

Invite

Jackson T. Wright — researcher profile on SciRah

Lara M. Simpson×6

Invite

Lara M. Simpson — researcher profile on SciRah

Mahboob Rahman×6

Invite

Mahboob Rahman — researcher profile on SciRah

Invite

J. Barzilay — researcher profile on SciRah